D. E. Shaw & Co., Inc. Uro Gen Pharma Ltd. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $137,922 - $208,185	10,843 New	10,843 $181,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $480,888 - $704,743	44,240 Added 131.54%	77,873 $1.17 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $297,315 - $761,451	33,633 New	33,633 $471,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.